ArticleOPEN ACCESS

Cytogenetics in CML: More important than you think

Blood
DOI: 10.1182/blood-2016-04-708206
7Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Wang et al describe that 2 groups of additional chromosomal abnormalities (ACAs) beyond the Philadelphia chromosome (Ph) impact prognosis in chronic myelogenous leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs)1.

Cite

CITATION STYLE

APA

Guilhot, F. (2016, June 2). Cytogenetics in CML: More important than you think. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-04-708206

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free